March 31, 2020
General Electric Completes Sale of BioPharma Business to Danaher for $21.4 Billion
Practices & Industries
Paul, Weiss advised General Electric in the sale of its BioPharma business to Danaher Corporation for $21.4 billion.
The Paul, Weiss team was led by M&A partners Scott Barshay and Steven Williams, and included, among others, partners Kyle Seifried, Michael Vogel and John Kennedy, and counsel Patricia Vaz de Almeida and Frances Mi; tax partners Jeffrey Samuels and Scott Sontag and counsel Alyssa Wolpin; intellectual property partners Claudine Meredith-Goujon and Jonathan Ashtor; employee benefits partner Lawrence Witdorchic; litigation partners William Clareman, Daniel Kramer, Jaren Janghorbani and Lewis Clayton and counsel Rachel Fiorill, Peter Jaffe and Daniel Mason; real estate partner Mitchell Berg; environmental counsel William O’Brien; and antitrust counsel Marta Kelly.
